Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SKYE | LGVN | APUS | ||
| Company | Skye Bioscience Inc | Longeveron Inc | Apimeds Pharmaceuticals US Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 0.7000 | 1.1100 | 1.6900 | ||
| High | 0.7290 | 1.2300 | 1.8899 | ||
| Low | 0.6802 | 1.0660 | 1.6900 | ||
| Latest | 0.7060 | 1.1600 | 1.8800 | ||
| Change | -0.0084 | +0.0600 | +0.1300 | ||
| % Change | -1.18% | +5.45% | +7.43% | ||
| Volume | 114,832 | 2,156,594 | 31,500 | ||
| 20-Day Average Volume | 1,177,972 | 16,231,369 | 110,590 | ||
| Previous Close | 0.7144 | 1.1000 | 1.7500 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.6664 | 0.9767 | 1.6745 | ||
| 20-Day Raw Stochastic | 52.13% | 89.01% | 73.01% | ||
| 20-Day Relative Strength | 47.79 | 65.92 | 55.65 | ||
| Weighted Alpha | -50.32 | -5.57 | -23.10 | ||
| Today's Opinion | 88% Sell | 72% Buy | 8% Sell | ||
| Previous Opinion | 88% Sell | 72% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.14% since 03/30/26 | +24.68% since 03/30/26 | +15.34% since 03/26/26 | ||
| Low | 0.5704 on 03/31/26 | 0.9200 on 03/31/26 | 1.6200 on 03/27/26 | ||
| High | 0.7290 on 04/07/26 | 1.2300 on 04/07/26 | 1.9100 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -2.00% since 03/06/26 | +139.87% since 03/06/26 | +39.26% since 03/02/26 | ||
| Low | 0.5655 on 03/30/26 | 0.4901 on 03/09/26 | 1.2700 on 03/04/26 | ||
| High | 0.8350 on 03/10/26 | 1.2300 on 04/07/26 | 2.1000 on 03/20/26 | ||
| 3-Month | |||||
| %Chg | -36.40% since 01/07/26 | +87.82% since 01/07/26 | +12.91% since 01/02/26 | ||
| Low | 0.5655 on 03/30/26 | 0.4750 on 03/06/26 | 0.9510 on 02/13/26 | ||
| High | 1.1400 on 01/08/26 | 1.2300 on 04/07/26 | 3.0000 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | -57.47% since 10/07/25 | +43.39% since 10/07/25 | +9.30% since 10/02/25 | ||
| Low | 0.5655 on 03/30/26 | 0.4750 on 03/06/26 | 0.9510 on 02/13/26 | ||
| High | 1.8137 on 10/08/25 | 1.2300 on 04/07/26 | 4.0310 on 11/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 23,846 | 25,595 | 23,643 | ||
| Shares Outstanding, K | 33,379 | 23,268 | 12,576 | ||
| Annual Sales | 0 | 1,200,000 | 0 | ||
| Annual Net Income | -55,920,000 | -22,700,000 | -1,390,000 | ||
| Last Quarter Sales | 0 | 370,000 | 0 | ||
| Last Quarter Net Income | -14,440,000 | -5,440,000 | -1,780,000 | ||
| 60-Month Beta | 2.87 | -0.18 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 03/10/26 | -0.22 on 03/17/26 | -0.14 on 11/12/25 | ||
| Latest Earnings Date | 05/14/26 | 05/14/26 | 05/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||